A Study to Evaluate Efficacy, of Early Versus Late Use of Vedolizumab in Crohn's Disease: the LOVE-CD Study

PHASE4CompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

May 26, 2023

Study Completion Date

May 26, 2023

Conditions
Crohn Disease
Interventions
DRUG

vedolizumab

Trial Locations (23)

3000

UZ Leuven, Leuven

Unknown

UZ Antwerpen, Antwerp

Imeldahospital, Bonheiden

AZ Sint-Lucas, Bruges

ULB Erasme, Brussels

Ziekenhuis Oost-Limburg, Genk

AZ Sint Lucas, Ghent

UZ Gent, Ghent

AZ Groeninge, Kortrijk

CHC Clinique Saint-Joseph, Liège

CHU de Liège, Liège

ZNA Jan Palfijn, Merksem

AZ Damiaan, Ostend

AZ Delta Roeselare, Roeselare

St Vincentius, Wilrijk

Semmelweis University, Budapest

University of Debrecen, Debrecen

Universtiy of Szeged, Szeged

Academisch Medisch Centrum, Amsterdam

Ziekenhuis Gelderse Vallei, Ede

OLVG, Leiden

Radboud Universitair Medisch Centrum, Nijmegen

Erasmus MC, Rotterdam

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

Geert D'Haens

OTHER